Last reviewed · How we verify

NCT06863051

Effect of Albumin Platelet-Rich Fibrin or Leucocyte- Platelet-Rich Fibrin on Immediate Implant

Recruiting now NA Last updated 1 August 2025
What this trial tests

NA trial testing Immediate Implant Placement and Alb-PRF in Immediate Implant Placement in 20 participants. Currently enrolling.

Timeline
20 August 2025
Primary endpoint
10 February 2026
10 February 2027

Quick facts

Lead sponsorKafrelsheikh University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date20 August 2025
Primary completion10 February 2026
Estimated completion10 February 2027
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Kafrelsheikh University

Who can join

Adults 18 to 45, any sex, with Immediate Implant Placement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study will be to compare between Immediate Implant grafted with xenograft and Alb-PRF gel versus xenograft with L-PRF.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Immediate Implant Placement

Currently open trials in the same condition.

Other Kafrelsheikh University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06863051.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing